The relevance of the MEK5–ERK5 route in the control of ovarian cancer cell proliferation was also supported by the finding that MEK5 KO cells, besides showing inactivation of ERK5, grew much less than wild type parental or Sc OVCAR8 cells, especially in the in vivo setting. Here, MAP2K5 is linked to ovarian carcinoma.